Cargando…

Echinocandins - first line in invasive candidiasis: how strong is this 'strong' evidence?

Detalles Bibliográficos
Autores principales:	Gonçalves-Pereira, João, Póvoa, Pedro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388707/ https://www.ncbi.nlm.nih.gov/pubmed/22182797 http://dx.doi.org/10.1186/cc10580

Ejemplares similares

Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation
por: Yeoh, Siang Fei, et al.
Publicado: (2018)

How to Create Memorizable and Strong Passwords
por: Cipresso, Pietro, et al.
Publicado: (2012)

Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients
por: Grau, S, et al.
Publicado: (2015)

Procalcitonin for the diagnosis of invasive candidiasis: what is the evidence?
por: Raineri, Santi Maurizio, et al.
Publicado: (2017)

First Case of Echinocandin-Resistant Candida albicans in Korea
por: Park, Min-Seung, et al.
Publicado: (2017)

Factors associated with the development of ocular candidiasis and ocular prognosis with echinocandin therapy for candidemia
por: Sakai, Daiki, et al.
Publicado: (2021)

Analysis of molecular resistance to azole and echinocandin in Candida species in patients with vulvovaginal candidiasis
por: Lotfali, Ensieh, et al.
Publicado: (2022)

Gel Formulations with an Echinocandin for Cutaneous Candidiasis: The Influence of Azone and Transcutol on Biopharmaceutical Features
por: Pérez-González, Noelia, et al.
Publicado: (2023)

157. A Multicenter, Mixed-Method Evaluation of Delayed Hospital Discharge in Patients with Invasive Candidiasis Receiving Echinocandins
por: Jo, Jinhee, et al.
Publicado: (2021)

Post-Prescription Audit Plus Beta-D-Glucan Assessment Decrease Echinocandin Use in People with Suspected Invasive Candidiasis
por: Murri, Rita, et al.
Publicado: (2021)

Clinical characteristics of the first cases of invasive candidiasis in China due to pan-echinocandin-resistant Candida tropicalis and Candida glabrata isolates with delineation of their resistance mechanisms
por: Xiao, Meng, et al.
Publicado: (2018)

Retrospective cohort study comparing the risk of severe hepatotoxicity in hospitalized patients treated with echinocandins for invasive candidiasis in the presence of confounding by indication
por: Vekeman, Francis, et al.
Publicado: (2018)

Seismogeodetic P‐wave Amplitude: No Evidence for Strong Determinism
por: Goldberg, D. E., et al.
Publicado: (2019)

Genetic Basis of Sjögren's Syndrome. How Strong is the Evidence?
por: Anaya, Juan-Manuel, et al.
Publicado: (2006)

Circadian rhythms: strong evidence on how to approach depression
por: Fountoulakis, Konstantinos N
Publicado: (2010)

Infectious endocarditis caused by Candida glabrata: evidence of in vivo development of echinocandin resistance
por: Agnelli, Caroline, et al.
Publicado: (2019)

2116. Comparative Effectiveness of Amphotericin B, Azoles, and Echinocandins in the Treatment of Candidemia and Invasive Candidiasis: A Systematic Review and Network Meta-Analysis
por: Demir, Koray K, et al.
Publicado: (2019)

Fluconazole and echinocandin resistance of Candida species in invasive candidiasis at a university hospital during pre-COVID-19 and the COVID-19 outbreak
por: Szekely, Jidapa, et al.
Publicado: (2023)

Candidiasis by Candida glabrata, Candida nivariensis and Candida bracarensis in Galleria mellonella: Virulence and Therapeutic Responses to Echinocandins
por: Hernando-Ortiz, Ainara, et al.
Publicado: (2021)

COVID-19 associated invasive candidiasis
por: Al-Hatmi, Abdullah M.S., et al.
Publicado: (2021)

Red and Processed Meats and Health Risks: How Strong Is the Evidence?
por: Qian, Frank, et al.
Publicado: (2020)

How strong is the evidence for electroweak corrections beyond the running of $\alpha$?
por: Sirlin, A
Publicado: (1993)

Strong yet incomplete reproductive isolation in Vermivora is not contradicted by other lines of evidence: A reply to Toews et al.
por: Porter, Cody K., et al.
Publicado: (2021)

From “Glivec(®)” to “Prevnar 13(®)”: How strong is the Indian drug patenting system?
por: Raj, Gerard Marshall
Publicado: (2018)

Response to Drs. Strong and Ficicioglu
por: Burton, Barbara K.
Publicado: (2023)

Significantly Improved Pharmacokinetics Enhances In Vivo Efficacy of APX001 against Echinocandin- and Multidrug-Resistant Candida Isolates in a Mouse Model of Invasive Candidiasis
por: Zhao, Yanan, et al.
Publicado: (2018)

Echinocandins: A ray of hope in antifungal drug therapy
por: Grover, Neeta D.
Publicado: (2010)

Strong Coupling beyond the Light-Line
por: Menghrajani, Kishan S., et al.
Publicado: (2020)

Assertiveness: how to be strong in every situation
por: Potts, Conrad, et al.
Publicado: (2013)

Strong interactions of strong particles
por: Snow, G A
Publicado: (1962)

Be strong you never know who you are inspiring
por: Ahmed, Amber
Publicado: (2021)

Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link?
por: Gaffo, Angelo L, et al.
Publicado: (2009)

How strong is the evidence base for carbohydrate restriction in the management of type 2 diabetes?
por: Frost, Gary
Publicado: (2022)

Fourteen southern galaxies with strong emission lines
por: West, R M
Publicado: (1976)

Comparison of echinocandin antifungals
por: Eschenauer, Gregory, et al.
Publicado: (2007)

Fungal echinocandin resistance
por: Walker, Louise A., et al.
Publicado: (2010)

Fungal echinocandin resistance
por: Munro, Carol A
Publicado: (2010)

How Strong Is the Hydrogen Bond in Hybrid Perovskites?
por: Svane, Katrine L., et al.
Publicado: (2017)

Norovirus–glycan interactions — how strong are they really?
por: Peters, Thomas, et al.
Publicado: (2022)

Aortic Arch Calcification on routine Chest Radiography is Strongly and Independently Associated with Non-Dipper Blood Pressure Pattern
por: Póvoa, Rui
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d4s484g2gqgqg6c4k52n7sp1n8